Our study revealed that AURKA expression increases with the progression of liver fibrosis (Figure 1A) and is positively correlated with ACTA2, a marker of activated HSCs (Figure 1B), as well as the fibrogenic genes COL1A1 and TIMP1 (Figure 1B; Supplementary Figure S1), based on publicly available gene expression datasets from liver fibrosis patients. This evidence concerns the gene TIMP1 and Hepatic fibrosis.